Voice your opinion on congressional bill S3311-118 and let lawmakers know your stance with UnPac!

Main Subject: Health

American Made Pharmaceuticals Act of 2023

This bill requires the Centers for Medicare & Medicaid Services to conduct a demonstration program that gives preference to domestically manufactured drugs under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP).

The program must be conducted in at least eight states and for at least seven years. Applicable drugs include critical drugs that are needed to respond to a public health emergency and that have a vulnerable global supply chain. Preference may take the form of reduced cost-sharing, preferential treatment on formularies, bonus payments, and other specified methods.

Senate Actions

Committee
Jul. 25 2024	Committee on Banking, Housing, and Urban Affairs. Hearings held.

IntroReferral
Nov. 15 2023	Read twice and referred to the Committee on Finance.

Library of Congress Actions

IntroReferral
Nov. 15 2023	Introduced in Senate

Senate bill S3311-118

American Made Pharmaceuticals Act of 2023

Senate bill S3311-118

American Made Pharmaceuticals Act of 2023

Promote the cause!

Or use this QR code